We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Takara Recombinant RNase Inhibitor, HQ. 40,000 U


Recombinant RNase Inhibitor, HQ (high quality) contains a mutation in a cysteine residue that is very sensitive to oxidation, making it highly stable in enzymatic reactions requiring low DTT concentrations. It inhibits RNase A activity through the formation of a 1:1 complex in a reversible reaction. It is not effective against RNase H activity.
Recombinant RNase Inhibitor, HQ has equivalent enzyme performance as Recombinant RNase Inhibitor ver.2.0 but has been produced with stricter quality standards and is supplied in a higher volume. It is intended for use in the preparation of active pharmaceutical ingredients (APIs) for non-clinical trials, as well as for the process development of drug manufacturing under good manufacturing practice (GMP) regulations.
| SKU | TAKBGN-2316A |
|---|---|
| Supplier Part Number | 2316A |
| UM | EA |
| UNSPSC | 12352200 |
| Manufacturer | Takara Bio |
| ProductLine | TAKBGN |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 5 |
| Hazardous | N |
| Energy Star | No |
| Green | No |
| Controlled | N |

